POINT Biopharma Global Overview
POINT Biopharma Global Target Price
Analysts' 12-month price predictions for PNT.
Get informed when a big investor buys or sells
+ FollowShare Price
$12.5
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2022-12-14 | Raymond James | $10 |  20% downside |  |
| 2022-11-30 | Leerink Partners | $14 |  12% upside | |
| 2022-11-15 | Truist Financial | $14 | 12% upside | |
| 2022-09-18 | Piper SandlerEdward Tenthoff | $17 | 36% upside | |
| 2022-09-11 | Piper SandlerEdward Tenthoff | $19 | 52% upside | |